Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog

by Shimizu Y, Nakakura S, Nishiyama M, Tabuchi H, Kiuchi Y
Published 2015-03-01

Ocular hypotensive effects of a Rho-associated protein kinase inhibitor in rabbits

by Kamaruddin MI, Nakamura-Shibasaki M, Mizuno Y, Kiuchi Y
Published 2017-03-01

Comparison of visual performance of toric versus non-toric intraocular lenses with same material

by Yamauchi T, Tabuchi H, Takase K, Ohara Z, Imamura H, Kiuchi Y
Published 2018-11-01

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial

by Kanamoto T, Ando N, Maruiwa F, Baba Y, Nakakura S, Tabuchi H, Kiuchi Y
Published 2012-03-01

Reproducibility of optic disk evaluation in supine subjects with a Heidelberg Retina Tomograph II laser tomographic scanner

by Harada Y, Akita T, Takenaka J, Nakamura-Kadohiro Y, Tanaka J, Kiuchi Y
Published 2016-08-01

Intraocular pressure readings obtained through soft contact lenses using four types of tonometer

by Takenaka J, Kunihara E, Rimayanti U, Tanaka J, Kaneko M, Kiuchi Y
Published 2015-10-01

The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study

by Okumichi H, Kiuchi Y, Baba T, Kanamoto T, Naito T, Nakakura S, Tabuchi H, Nii H, Sueoka C, Sugimoto Y
Published 2017-06-01

Prostaglandin-associated periorbitopathy in latanoprost users

by Nakakura S, Yamamoto M, Terao E, Nagatomi N, Matsuo N, Fujisawa Y, Fujio Y, Tabuchi H, Kiuchi Y
Published 2014-12-01

Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently

by Sato N, Nakamura Y, Yamadera S, Inagaki M, Kenmotsu S, Saito H, Oguchi T, Tsuji M, Chokki H, Ohsawa I, Gotoh H, Iwai S, Kiuchi Y
Published 2019-10-01